Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol.
Shu ZhuLina WuYongyu MeiZhihua LiuLuping LinJing YuanJianguo LiXuejun LiLiang PengPublished in: BMJ open (2021)
NCT04640129.